UplaObserver
Uplisting

Hawkeye Digital 8-K Deck Flags Uplisting Requirements and Risks

Hawkeye Digital's Oct. 16 8-K furnishes an investor deck that lists a national exchange listing as a medium-term goal while warning no uplisting is assured.

Oct 16, 20263 min read

A company that wants to move from the OTC market to a national exchange has to persuade two audiences at once: investors who must fund the journey, and an exchange that will test the result against listing standards. Hawkeye Digital, Inc. (HWKE), a Miami Beach company that describes itself as a public incubator, put that tension on the record this month with an 8-K that furnishes its investor presentation.

What the filing contains

The Form 8-K, filed Oct. 16, 2026, has a single operative item. Under Item 7.01, Regulation FD Disclosure, the company says it made an investor presentation available on Oct. 13, 2026 and attaches it as Exhibit 99.1. The filing states that the information is furnished rather than filed, so it is not incorporated into other SEC filings. The company is a Nevada corporation with a fiscal year ending June 30, and the presentation refers to its annual report on Form 10-K for fiscal 2026.

The deck was prepared for prospective investors who have represented that they are accredited. It describes a strategy of taking minority and control stakes in digital asset, future finance and frontier technology companies, while earning merchant banking and advisory fees from the same businesses.

The uplisting language

Two passages in the deck bear directly on uplisting requirements. The first is a roadmap. Under a medium-term phase, management lists scaling the incubator and merchant banking platform, evaluating a possible acquisition of a FINRA member broker-dealer, and preparing for a national exchange listing. The roadmap adds that timing depends on financing, transaction execution, market conditions and regulatory factors. On the broker-dealer, it says professionals have been retained but no agreement is in place.

The second is a disclaimer. The risk summary says the common stock trades on the OTC market with limited liquidity and that “there is no assurance of an uplisting.” A closing note repeats that no assurance can be given that listing standards will be met.

The deck sells uplisting as a service to clients and as an ambition for the company, but only the second comes with a caveat that the standards may not be met.

That contrast reflects how the presentation is built. Among the advisory services Hawkeye offers to portfolio companies are mergers into a public company, up-listing to a national exchange with listing readiness, governance and execution for Nasdaq or NYSE American, and IPOs or follow-on offerings. For itself, the deck names no exchange or date.

How the model is meant to work

The presentation lays out a three-part earning model using a transaction it calls Pubco. According to the deck, Hawkeye advises Pubco on a combination with Infrastructure Development Company for a $300,000 cash fee at closing. It also purchased 91.7 million warrants for $550,000, at $0.006 each with a $0.004 exercise price and a term to October 2031, and earned 16.7 million fee warrants on the same terms. A separate option covers 4.5 million shares at $0.01 through March 2027. The deck presents the arithmetic as illustrative: the cash fee offsets much of the capital at risk, and the equity carries the upside.

The risk section is direct about the dependencies. It cites a limited operating history as an incubator and merchant bank, a need for additional capital that may be dilutive, illiquid and speculative portfolio holdings, evolving digital asset regulation, and related-party interests among officers, directors and significant shareholders.

Why it matters for OTC issuers

Companies on the OTC market considering a move to Nasdaq or NYSE American face the same sequence Hawkeye outlines: build a track record, raise capital, strengthen governance and then apply under listing standards that the company cannot control. Hawkeye’s filing is useful less for its specifics than for how plainly it separates the plan from the outcome.

For readers following OTC-to-exchange moves, the next markers would be the company’s quarterly reports following its fiscal 2026 Form 10-K, filed Sept. 11, 2026, any financing that changes the share count, and any application or board action tied to a listing. None is announced in this filing.

Prepared with AI assistance from public sources and reviewed under our editorial policy. Not investment advice.

Related